FibroGen, Inc.的动态

Connected together, we can make a big impact. BioLinked is building an innovative network connecting biomedical organizations, ideally matched participants and blood centers. We’re creating new pathways for a healthy world where all people benefit from biomedical advancements. Ready to make a difference? Register to become a BioLinked participant and you will be notified when you are a potential match in a clinical trial or study! #ConnectedTogether #ImpactfulConnections #BiomedicalAdvancements https://lnkd.in/gsued-v4

In this new Clinical Supply Leader article, Allan Gibson of Bill & Melinda Gates Medical Research Institute shares key learnings and insights around #qualityassurance coming out of Gates MRI's vaccine #clinicaltrials in low- and middle-income countries. https://lnkd.in/eKd_amsa #LMICs #clinicalsupply #supplyplanning

Today is #InternationalClinicalTrialsDay! As Sponsor of innovative clinical trials, GCAR is dedicated to the advancement of science by modernizing clinical trials to accelerate the time from discovery in the lab to use in the clinic resulting in better treatments and lives saved. To learn more about our research, visit: gcaresearch.org #clinicalresearch #clinicaltrials #masterprotocol #platformtrial

?? Upcoming Session at #ALFC2024: Dr. Dan Siman-Tov, Senior Director of R&D at Meridian Bioscience Inc. We're looking forward to Dr. Dan Siman-Tov's insightful session at the Advanced #LateralFlow Conference. As the Senior Director of R&D in Diagnostics at Meridian Bioscience, Dr. Siman-Tov brings his extensive experience to his session titled "Lateral Flow Diagnostics: Challenges, Advantages, and Technical Guidelines." ?? Why This Session Is Crucial: Expert Insights: With Dr. Siman-Tov's extensive background in diagnostics, attendees will gain a comprehensive understanding of the current challenges and advantages in lateral flow technology. Practical Guidance: Learn about essential technical guidelines that are critical for developing and enhancing lateral flow diagnostic tests. Future Trends: Explore how the field is evolving and what we can expect in terms of innovation and application. ?? This session is perfect for professionals in R&D, quality assurance, and anyone involved in the development and application of lateral flow diagnostics. Don’t miss the opportunity to gain valuable knowledge from a leading expert in the field. ?? Haven't registered yet? Registration ends February 9 and the hotel room block closes January 26! Register here: https://lnkd.in/emRskqjd #IVD #LFA #Diagnostics #Innovation #MeridianBioscience

#TuneIn to hear our CEO, Marc Hertz, PhD, highlight our recent clinical developments. https://lnkd.in/dPNKZ7Tm #NKT #FibroticDisease #PulmonaryDisease #AutoimmuneDisease

Our Chief Medical Officer, Dr. Fairooz Kabbinavar M.D., FACP, sat down with Clinical Leader to discuss a pivotal moment in Cardiff Oncology’s journey—our decision to transition our lead clinical development program from second-line to first-line RAS-mutated metastatic #colorectalcancer. In this Q&A, Dr. Kabbinavar shares the data that drove this decision, the collaborative conversations with the #FDA, and what this could mean for the future of mCRC treatment and patients. Interested in the strategy behind #clinicaltrial design? Then this interview is a must-read! https://lnkd.in/eMU-DemU #innovation #cancerresearch

From the last two days at #ASNC2024, I can conclude that physicians, technologists, bioengineers, image applicators, and scientists have made significant breakthroughs in the clinical diagnosis of myocardial amyloidosis and sarcoidosis. This underscores the paramount importance of multidisciplinary teams; the more collaboration, the clearer the research outcomes and guidelines.

It is my pleasure to share with you our recent publication titled: Milestones for Establishing Effective Research Activity and Education in Health and Social Care Organization You might access the full article through https://lnkd.in/eRXij7C8 Enjoy reading! Dr. Nagwa Ibrahim, Global Journal of Medical Therapeutics #researchactivity, #research, #education, #socialcareorganization

Explore the critical components of assay monitoring with our latest infographic, featured in our In the Zone. We cover the importance of both assay performance and maintenance, offering insights into overcoming key challenges. This infographic is a must-see for anyone involved in clinical research! >>> https://hubs.ly/Q02NMyzJ0

Save the date! Join us this Thursday, April 25 at 12 pm ET for a webinar featuring MEDITECH’s Manager of Clinical Product Management, Jennifer Ford, MBA Ford, and GenomOncology’s Vice President of Product Innovation, James Cole, PhD. During the webinar, learn how our collaborative efforts are reshaping precision medicine, as we dive into how MEDITECH has further strengthened Expanse Genomics through its partnership with GenomOncology.?See first-hand how this integration outputs evidence-based therapy guidance and clinical trial matching right within the EHR! Register now to learn more: https://lnkd.in/euG2eaKg #PrecisionMedicine #Webinar #ClinicalTrials #Therapies